Barrow破裂动脉瘤试验囊状动脉瘤10年分析
Barrow破裂动脉瘤试验将362例囊状动脉瘤患者等量随机分配至夹闭组与栓塞组(各181例),10年随访显示两组不良结局(mRS>2)或死亡无统计学显著差异。实际接受夹闭者的完全闭塞率与再治疗率优于栓塞者,但后循环动脉瘤1年时栓塞组临床结局更优,1年后差异不再显著。
要点
- 10年随访两组不良结局(mRS>2)或死亡无统计学显著差异。
- 实际夹闭动脉瘤完全闭塞率93%(50/54)vs 栓塞22%(5/23),p<0.001。
- 实际夹闭后再治疗2/241(0.8%)vs 栓塞23/115(20%),p<0.001。
核心结论
- 两 assigned 治疗组以mRS结局或死亡衡量的临床结局无显著差异。
- 后循环动脉瘤患者1年时栓塞组临床结局更好,但1年后该差异不再有统计学显著性。
- 实际接受夹闭者的动脉瘤完全闭塞率和再治疗率优于实际接受栓塞者。
研究设计与样本
- Barrow破裂动脉瘤试验(BRAT)10年结果分析,纳入362例囊状动脉瘤患者,等量随机分配至夹闭组与栓塞组(各181例)。
- 主要结局分析基于 assigned 治疗组,不良结局定义为改良Rankin量表(mRS)评分>2,由独立裁定。
- 动脉瘤闭塞程度由非治疗神经放射科医生裁定。
主要发现
- 178例 assigned 夹闭的囊状动脉瘤患者中1例(<1%)交叉至栓塞,178例 assigned 栓塞患者中64例(36%)交叉至夹闭。
- 初次住院后,241例实际夹闭的囊状动脉瘤中2例(0.8%)需再治疗,115例实际栓塞的囊状动脉瘤中23例(20%)需再治疗(p<0.001)。
- 10年随访时,实际夹闭动脉瘤完全闭塞93%(50/54),实际栓塞动脉瘤仅22%(5/23)(p<0.001)。
- 2例记录到再出血且均死亡,均属于 assigned 并实际栓塞队列(2/83);实际夹闭队列无死亡(0/175)(p=0.04)。
- 上述2例再出血中1例出血并非来自目标动脉瘤,而是来自同时栓塞的偶然基底动脉动脉瘤。
关键数值与推荐
- 不良结局定义:mRS评分>2。
- 再治疗率:实际夹闭2/241(0.8%)vs 实际栓塞23/115(20%),p<0.001。
- 完全闭塞率:实际夹闭93%(50/54)vs 实际栓塞22%(5/23),p<0.001。
- 再出血死亡:实际栓塞队列2/83 vs 实际夹闭队列0/175,p=0.04。
临床怎么用
- 原文未据此给出推荐。
- 作者报告两 assigned 治疗组以mRS结局或死亡衡量的临床结局无显著差异。
- 作者报告实际接受夹闭者的完全闭塞率和再治疗率优于实际接受栓塞者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The authors present the 10-year results of the Barrow Ruptured Aneurysm Trial (BRAT) for saccular aneurysms. The 1-, 3-, and 6-year results of the trial have been previously reported, as have the 6-year results with respect to saccular aneurysms. This final report comparing the safety and efficacy of clipping versus coiling is limited to an analysis of those patients presenting with subarachnoid hemorrhage (SAH) from a ruptured saccular aneurysm. METHODS: In the study, 362 patients had saccular aneurysms and were randomized equally to the clipping and the coiling cohorts (181 each). The primary outcome analysis was based on the assigned treatment group; poor outcome was defined as a modified Rankin Scale (mRS) score > 2 and was independently adjudicated. The extent of aneurysm obliteration was adjudicated by a nontreating neuroradiologist. RESULTS: There was no statistically significant difference in poor outcome (mRS score > 2) or deaths between these 2 treatment arms during the 10 years of follow-up. Of 178 clip-assigned patients with saccular aneurysms, 1 (< 1%) was crossed over to coiling, and 64 (36%) of the 178 coil-assigned patients were crossed over to clipping. After the initial hospitalization, 2 of 241 (0.8%) clipped saccular aneurysms and 23 of 115 (20%) coiled saccular aneurysms required retreatment (p < 0.001). At the 10-year follow-up, 93% (50/54) of the clipped aneurysms were completely obliterated, compared with only 22% (5/23) of the coiled aneurysms (p < 0.001). Two patients had documented rebleeding, both died, and both were in the assigned and treated coiled cohort (2/83); no patient in the clipped cohort (0/175) died (p = 0.04). In 1 of these 2 patients, the hemorrhage was not from the target aneurysm but from an incidental basilar artery aneurysm, which was coiled at the same time. CONCLUSIONS: There was no significant difference in clinical outcomes between the 2 assigned treatment groups as measured by mRS outcomes or deaths. Clinical outcomes in the patients with posterior circulation aneurysms were better in the coiling group at 1 year, but after 1 year this difference was no longer statistically significant. Rates of complete aneurysm obliteration and rates of retreatment favored patients who actually underwent clipping compared with those who underwent coiling.Clinical trial registration no.: NCT01593267 (clinicaltrials.gov).
引用
- Spetzler RF, McDougall CG, Zabramski JM, et al. Ten-year analysis of saccular aneurysms in the Barrow Ruptured Aneurysm Trial. J Neurosurg. 2019. PMID: 30849758. doi:10.3171/2018.8.JNS181846
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。